TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

NCT00848198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2016-05-16

Study results available
· View outcomes & findings →

Summary

This is a prospective, observational case series to determine the clinical utility of tear osmolarity and other commonly used objective tests to diagnose dry eye disease, as well as to establish referent values for objective tests of the disease.

Conditions

  • Keratoconjunctivitis Sicca

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY
  • TearLab Corporation

    lead INDUSTRY

Principal Investigators

  • Gary Foulks, MD · Kentucky Lions Eye Center, University of Louisville

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States
  • France
  • Germany
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00848198 on ClinicalTrials.gov